Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, premixes, food and beverage fortification, veterinary, feed, and rodenticides; pharmaceutical ingredients comprising phenyramidol and silicon dry powder; nutritional premixes; and enzymes for use in oleochemicals, fine chemicals, active pharmaceutical ingredients, food and fragrances, leather, and biodiesel industries. In addition, it engages in the design, engineering, procurement, and construction
| Current Price | ₹313.40 |
|---|---|
| Market Cap | ₹922 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 12.8 |
| Return on Equity | 18.51% |
| 52-Week Range | ₹256.40 – ₹399.00 |
| Beta (1Y) | -0 |
| Dividend Yield | 1.20% |
Fermenta Biotech Ltd is trading at ₹313.40, with a market capitalisation of ₹922 Cr.
Fermenta Biotech Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Fermenta Biotech Ltd has a P/E of 12.8 and a return on equity of 18.51%.